Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis

Derince Training and Research Hospital

Status: Unknown

Conditions: INTERLEUKIN 6

Treatments: Device: cytokine hemadsorption

Study type: Observational

Funder types: Other

Identifiers

NCT04920851

BIRUNI 1

Details and patient eligibility

About

In this retrospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis.

Enrollment: 23 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COVID-19 patients were the available data of laboratory diagnosis of COVID-19 (a positive throat swab nucleic acid test or positive serum COVID-19 specific antibody test),
• patients with COVID-19 induced sepsis was detection of bacterial agent in blood or tracheal culture

Exclusion criteria

• below 18 aged
• those who did not undergo hemoperfusion

Trial design

23 participants in 2 patient groups

Covid with sepsis

Description:

Covid patient with sepsis

Treatment:

Device: cytokine hemadsorption

covid without sepsis

Description:

Covid patient without sepsis

Treatment:

Device: cytokine hemadsorption